Shares of Chemfab Alkalis Limited declined by 9.29%, trading at ₹1,007.25 on the NSE as of 9:22 am, following its Q2 FY2025 financial results. The company’s earnings report showed a decline in EBITDA by 7% and a drop in EBITDA margin to 12.3% from 13.6% year-on-year (YoY).
Quarterly Performance Highlights: For the second quarter ending September 30, 2024, Chemfab Alkalis reported:
- Revenue: ₹824.97 million, up slightly from ₹810.38 million YoY.
- Net Loss: ₹5.34 million, compared to a net income of ₹43.03 million in the previous year.
- EPS (Basic and Diluted): Loss of ₹0.37 per share, down from earnings of ₹3 per share YoY.
Six-Month Period Highlights:
- Sales: ₹1,584.27 million, nearly unchanged from ₹1,586.59 million YoY.
- Revenue: ₹1,616.22 million, a slight decrease from ₹1,637.94 million last year.
- Net Income: ₹3.61 million, significantly down from ₹138.12 million YoY.
- EPS: Earnings of ₹0.25 per share, down from ₹9.63 per share YoY.
The results reflect a challenging period for Chemfab, marked by lower profitability and a net loss in Q2 compared to last year’s gains.
